ACE-Hemmer und das Lungenkrebsrisiko - was Ärzte bedenken sollten
Crossref DOI link: https://doi.org/10.1007/s15006-021-9603-6
Published Online: 2021-02-18
Published Print: 2021-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
van der Giet, Markus
Text and Data Mining valid from 2021-02-01
Version of Record valid from 2021-02-01
Article History
First Online: 18 February 2021